Moreover, in vitro studies on Cal 27 cells and xenograft mouse model support the potential of SIRT1 as tumor suppressor in oral cancer and provide the rationale for the use SIRT1 activators from dietary source in the setting of new prevention strategies [22]. This evidence concerns the gene SIRT1 and lip and oral cavity carcinoma.